Objective: To compare the flavour and taste preferences of two acid-inhibitory therapies in children. Subjects and Setting: 104 (52 male and 52 female) healthy children aged 6-11 years participated in ...

This work aimed to investigate the co-grinding effects of β-cyclodextrin (β-CD) and cucurbit[7]uril (CB[7]) on crystalline zaltoprofen (ZPF) in tablet formulation. Crystalline ZPF was prepared through ...

Please provide your email address to receive an email when new articles are posted on . Neos Therapeutics Inc. recently announced the FDA approved Cotempla XR-ODT, an extended-release orally ...

Drug delivery as solid dosage forms is complex with a number of factors that can noticeably influence their therapeutic benefit. The drug must be stabilized in the tablet and at the same time be ...

The US Food and Drug Administration (FDA) on Thursday issued new draft guidance covering the quality attributes drugmakers should consider when developing chewable tablets. The guidance also includes ...

The study was conducted at a contract research organisation site (Hilltop Research, Inc., Scottsdale, AZ, USA). Healthy children from 6 to 11 years of age, with a minimum bodyweight of 16.8kg (37lbs), ...